Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
erepoxen
- Development stage
- Unknown
- Lead developer
- Pharmsynthez
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Administration
- Subcutaneous
01
Overview
ErepoXen is a **polysialylated form of recombinant human erythropoietin (EPO)** developed to treat anemia, particularly in pre-dialysis patients with chronic kidney disease. The addition of polysialic acid extends the half-life of EPO, enabling less frequent dosing (up to once a month), and is intended to reduce immunogenicity and side effects compared to standard erythropoietin-based therapies. Its mechanism of action is **agonism of the erythropoietin receptor**, stimulating erythropoiesis (red blood cell production) in the bone marrow. ErepoXen uses Xenetic Biosciences’ PolyXen® technology and has been developed in collaboration with Serum Institute of India and SynBio. It is currently in Phase 2/3 development for anemia[2][4][5][6][7][8].
- Brand names
- ErepoXen
- Other names
- ErepoXenpolysialylated erythropoietinEpolongpolysialic EPOpolysialic erythropoietin
02
Targets
Erythropoietin Receptor
Beyond the preview
Go deeper on erepoxen.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on erepoxen.